Search

Search Constraints

You searched for: Author/Creator Lim, Jeffrey Chun Tatt

Search Results

11. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

12. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

13. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

14. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

15. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

16. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

17. Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma. Issue 2 (26th August 2020)

18. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases. Issue 9 (27th May 2015)

19. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression. Issue 10 (7th April 2016)

20. Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC. Issue 9 (22nd January 2020)